ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Aripiprazole in Adolescents With Schizophrenia

ClinicalTrials.gov ID: NCT00102063

Public ClinicalTrials.gov record NCT00102063. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 10, 2026, 11:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00102063
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Industry
Enrollment
302 participants

Conditions and interventions

Conditions

Interventions

  • Aripiprazole tablet, 10 mg Drug
  • Aripiprazole tablet, 30 mg Drug
  • Placebo tablet Drug

Drug

Eligibility (public fields only)

Age range
13 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2004
Primary completion
Jul 31, 2006
Completion
Jul 31, 2006
Last update posted
Aug 9, 2012

2004 – 2006

United States locations

U.S. sites
53
U.S. states
27
U.S. cities
53
Facility City State ZIP Site status
Local Institution Birmingham Alabama
Local Institution Little Rock Arkansas
Local Institution Costa Mesa California
Local Institution Los Angeles California
Local Institution National City California
Local Institution Orange California
Local Institution Pasadena California
Local Institution Sacramento California
Local Institution San Diego California
Local Institution Temecula California
Local Institution Washington D.C. District of Columbia
Local Institution Altamonte Springs Florida
Local Institution Fort Lauderdale Florida
Local Institution Gainesville Florida
Local Institution Hialeah Florida
Local Institution Jacksonville Florida
Local Institution Miami Florida
Local Institution North Miami Florida
Local Institution Orange City Florida
Local Institution Tampa Florida
Local Institution Newnan Georgia
Local Institution Smyrna Georgia
Local Institution Honolulu Hawaii
Local Institution Chicago Illinois
Local Institution Kansas City Kansas
Local Institution Lexington Kentucky
Local Institution Lake Charles Louisiana
Local Institution New Orleans Louisiana
Local Institution Medford Massachusetts
Local Institution Clinton Township Michigan
Local Institution Flowood Mississippi
Local Institution Kansas City Missouri
Local Institution Las Vegas Nevada
Local Institution Elmsford New York
Local Institution New York New York
Local Institution Olean New York
Local Institution Rochester New York
Local Institution Chapel Hill North Carolina
Local Institution Cleveland Ohio
Local Institution Lyndhurst Ohio
Local Institution Oklahoma City Oklahoma
Local Institution Bala-Cynwyd Pennsylvania
Local Institution Philadelphia Pennsylvania
Local Institution Memphis Tennessee
Local Institution Bellaire Texas
Local Institution DeSoto Texas
Local Institution Houston Texas
Local Institution San Antonio Texas
Local Institution Salt Lake City Utah
Local Institution Richmond Virginia
Local Institution Kirkland Washington
Local Institution Spokane Washington
Local Institution Wauwatosa Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00102063, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 9, 2012 · Synced May 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00102063 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →